CDRH's Burlington on drug model
This article was originally published in The Gray Sheet
Executive Summary
FDA Center for Devices and Radiological Health Director Bruce Burlington pledges at "all hands" staff meeting March 3 that he is "not going to transfer the so-called 'drug model' from" the Center for Drug Evaluation and Research to the device center. Burlington added that he "is not going to be satisfied with halfway measures when it comes to scientific rigor in the device review process." Burlington was a CDER topsider before moving to CDRH Feb. 22 ("The Gray Sheet" Feb. 8, p. 1).